KINNATE BIOPHARMA INC's ticker is KNTE and the CUSIP is 49705R105. A total of 86 filers reported holding KINNATE BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,889 | -54.2% | 27,778 | -0.8% | 0.00% | – |
| Q2 2023 | $84,867 | -93.6% | 28,009 | -86.8% | 0.00% | – |
| Q1 2023 | $1,324,094 | +1.0% | 211,855 | -1.4% | 0.00% | – |
| Q4 2022 | $1,310,378 | -50.3% | 214,816 | -2.6% | 0.00% | -100.0% |
| Q3 2022 | $2,636,000 | -7.3% | 220,624 | -2.2% | 0.00% | 0.0% |
| Q2 2022 | $2,845,000 | +21.5% | 225,606 | +8.5% | 0.00% | – |
| Q1 2022 | $2,341,000 | -38.1% | 207,837 | -2.7% | 0.00% | -100.0% |
| Q4 2021 | $3,784,000 | -22.2% | 213,537 | +1.0% | 0.00% | 0.0% |
| Q3 2021 | $4,865,000 | +54.2% | 211,353 | +56.0% | 0.00% | 0.0% |
| Q2 2021 | $3,155,000 | -30.4% | 135,513 | -6.9% | 0.00% | 0.0% |
| Q1 2021 | $4,536,000 | – | 145,608 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 9,671,643 | $225,156,000 | 30.44% |
| Vida Ventures Advisors, LLC | 2,747,433 | $63,960,000 | 16.04% |
| Foresite Capital Management V, LLC | 875,001 | $20,370,000 | 8.01% |
| VR Adviser, LLC | 1,473,014 | $34,292,000 | 4.16% |
| Logos Global Management LP | 1,329,602 | $30,953,000 | 2.60% |
| RA Capital Management | 3,593,052 | $83,646,000 | 1.34% |
| Orbimed Advisors | 3,847,929 | $89,580,000 | 0.91% |
| Boxer Capital, LLC | 1,065,939 | $24,815,000 | 0.88% |
| HARVARD MANAGEMENT CO INC | 498,001 | $11,593,000 | 0.67% |
| HighVista Strategies LLC | 33,391 | $777,000 | 0.55% |